(Q38136127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Human papillomavirus: current status and issues of vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Heena Malik

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Fahim H Khan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

1 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

199-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022639%20AND%20SRC:MED&resulttype=core&format=json

Classification of papillomaviruses

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Papillomavirus and disease in humans and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Papillomaviruses in the causation of human cancers - a brief historical account

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Position paper--HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus and HPV vaccines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Interactions between papillomavirus L1 and L2 capsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Mechanisms of cell entry by human papillomaviruses: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus oncoproteins: pathways to transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Down-regulation of MHC class I is a property common to papillomavirus E5 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus and vaccination in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

New viral vaccines for dermatologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Advances in peptide-based human papillomavirus therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papilloma virus vaccines: Current scenario

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Cervical cancer in India and HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Cancer in the developing world: a call to action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Prospects for new human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Potential benefits of second-generation human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

DNA vaccines for cervical cancer: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z

Vaccination to prevent and treat cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1827-Z